RNART
Dead / Cancelled — Cancelled — Section 8 (as of 19 Sept 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86119892
- Registration number
- 4694261
- Mark type
- Stylized text
- Filed
- 15 Nov 2013
- Published for opposition
- 16 Dec 2014
- Registered
- 03 Mar 2015
- Attorney of record
- Jennifer Fraser
Goods and services
- Class 001 — Chemicals: Chemical products and biomolecules, namely, biological macromolecules used for industrial and scientific purposes; reagents for research use
- Class 005 — Pharmaceuticals: CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; PHARMACEUTICAL AND VETERINARY MEDICAL PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; IMMUNOSTIMULATORY COMPOSITIONS; VACCINES, ADJUVANT IMMUNOSTIMULANTS; PHARMACEUTICALS AND MEDICAMENTS BASED ON/CONTAINING/PREPARED FROM BIOLOGICAL MACROMOLECULES FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; GENE THERAPY PRODUCTS, NAMELY, NUCLEIC ACID MACROMOLECULES FOR IN VIVO EXPRESSION; FOOD SUPPLEMENTS FOR MEDICAL USE
- Class 042 — Scientific and technological services: Scientific and technological services and research work, namely, the identification and characterization of biological macromolecules
- Class 044 — Medical, beauty and agricultural services: [ MEDICAL AND VETERINARY MEDICAL SERVICES, namely, THERAPEUTIC AND PREVENTIVE TREATMENT OF TUMORS, INFECTIOUS OR AUTOIMMUNE DISEASES AND ALLERGIES; TREATMENT OF HERITABLE DISEASES; MEDICAL SERVICES IN THE NATURE OF MEDICAL THERAPIES REPLACING PROTEINS OR ENZYMES; TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES; AND TREATMENT OF METABOLIC DISEASES ]
Owner
- CUREVAC SE, TÜBINGEN, DE
- CUREVAC AG, TUEBINGEN, DE
- CureVac GmbH, Tubingen, DE
- CureVac GmbH, Tubingen, DE
- CureVac GmbH, Tubingen, DE
Prosecution history
- 19 Sept 2025 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 03 Mar 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Mar 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Jul 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Jul 2021 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Jul 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Mar 2021 — TEAS SECTION 8 & 15 RECEIVED
- 03 Mar 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jun 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jun 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Nov 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Mar 2015 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2014 — PUBLISHED FOR OPPOSITION
- 26 Nov 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED